Overexpression of miR-126 inhibits the activation and migration of HSCs through targeting CRK

Cellular Physiology and Biochemistry

Volumn 33, Issue 1, 2014, Pages 97-106

  Gong, Xu Hua ^a   Chen, Chao ^b   Hou, Peng ^b   Zhu, Song Cheng ^c   Wu, Chao Qun ^d   Song, Chen Lin ^c   Ni, Wu ^a   Hu, Jiang Feng ^a   Yao, Ding Kang ^a   Kang, Jiu Hong ^c   Zhu, Liang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c Tongji Universities   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

Activation; CRK; HSCs; miR 126

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; CRK LIKE PROTEIN; MICRORNA 126; CRK PROTEIN, RAT; MICRORNA; MIRN126 MICRORNA, RAT; ONCOPROTEIN; CRK PROTEIN; F ACTIN; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL COUNTING; CELL MIGRATION; CELL PROLIFERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; LUCIFERASE ASSAY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; WESTERN BLOTTING; ANIMAL; CELL LINE; CELL MOTION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SPRAGUE DAWLEY RAT; STELLATE CELL; 3' UNTRANSLATED REGION; CELL ASSAY; CELL CULTURE; CELL ISOLATION; CELL SHAPE; CONTROLLED STUDY; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; IN VITRO STUDY; LENTIVIRUS INFECTION; LOCOMOTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

LENTIVIRUS;

ANIMALS; BASE SEQUENCE; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN TYPE I; GENE EXPRESSION REGULATION; HEPATIC STELLATE CELLS; MALE; MICRORNAS; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS C-CRK; RATS, SPRAGUE-DAWLEY;

EID: 84893183120     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000356653     Document Type: Article

References (18)

1. Cheng K, Ye Z, Guntaka RV, Mahato RI: Biodistribution and hepatic uptake of triplex-forming oligonucleotides against type alphal(I) collagen gene promoter in normal and fibrotic rats: Mol Pharm 2005;2:206-217.
2. Kawada N: Evolution of hepatic fibrosis research. Hepatol Res 2011;41:199-208.
3. Guo CJ, Pan Q, Li DG, Sun H, Liu BW: miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis. J Hepatol 2009;50:766-778.
4. Ji J, Zhang J, Huang G, Qian J, WangX, MeiS: Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 2009;583:759-766.
5. Venugopal SK, Jiang J, Kim TH, Li Y, Wang SS, Torok NJ, Wu J, Zern MA: Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol 2010;298:G101-106.
6. Li J, Zhang Y, Kuruba R, Gao X, Gandhi CR, Xie W, Li S: Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells. Mol Pharmacol 2011;80:191-200.
7. Ogawa T, Enomoto M, Fujii H, Sekiya Y, Yoshizato K, Ikeda K, Kawada N: MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut 2012;61:1600-1609.
8. Li WQ, Chen C, Xu MD, Guo J, Li YM, Xia QM, Liu HM, He J, Yu HY, Zhu L: The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine- induced hepatic fibrosis in rats. FEBS[ 2011;278:1522-1532.
9. Marquez RT, Bandyopadhyay S, Wendlandt EB, Keck K, Hoffer BA, Icardi MS, Christensen RN, Schmidt WN, McCaffrey AP: Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest 2010;90:1727-1736.
10. Sekiya Y, 0 gawa T, Iizuka M, Yoshizato K, Ikeda K, Kawada N: Down-regulation of cyclin El expression by microRNA-195 accounts for interferon-beta-induced inhibition of hepatic stellate cell proliferation. J Cell Physiol 2011;226:2535-2542.
11. Chen C, Wu CQ, Zhang ZQ, Yao DK, Zhu L: Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation. Exp Cell Res 2011;317:1714-1725.
12. Sun Y, Bai Y, Zhang F, Wang Y, Guo Y, Guo L: miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.Biochem Biophys Res Commun 2010;391:1483-1489.
13. Liu B, Peng XC, Zheng XL, Wang J, Qin YW: MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 2009;66:169-175.
14. Feng R, Chen X, Yu Y, Su L, Yu B, Li J, Cai Q, Yan M, Liu B, Zhu Z: miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 2010;298:50-63.
15. Guo C, Sah JF, Beard L, Willson JK, Markowitz SD, Guda K: The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 2008;47:939-946.
16. Antoku S, Mayer BJ: Distinct roles for Crk adaptor isoforms in actin reorganization induced by extracellular signals. J Cell Sci 2009;122:4228-238.
17. Stoletov KV, Gong C, Terman BI: Nek and Crk mediate distinct VEGF-induced signaling pathways that serve overlapping functions in focal adhesion turnover and integrin activation. Exp Cell Res 2004;295:258-268.
18. Cho SY, Klemke RL: Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix. J Cell Biol 2000;149:223-236.